MyFinsight
Home
About
Contact
Back
Income Statement
BIOGEN INC. (BIIB)
source: myfinsight.com
Download
Download image
LEQEMBICollaboration
$54,900K
Revenuesfromanticd20therapeuticprograms
$467,300K
(5.13%↑ Y/Y)
Product And Service
Other
$244,600K
(102.48%↑ Y/Y)
Product
$1,878,700K
(-1.10%↓ Y/Y)
Total revenue
$2,645,500K
(7.33%↑ Y/Y)
Income before income
tax (benefit)...
$744,000K
(6.48%↑ Y/Y)
Total cost and expense
$1,901,500K
(7.66%↑ Y/Y)
Restructuring charges
-$700K
(-110.61%↓ Y/Y)
Net income
attributable to biogen inc
$634,800K
(8.77%↑ Y/Y)
Income tax (benefit)
expense
$109,200K
(-5.13%↓ Y/Y)
Amortization and impairment
of acquired...
$130,900K
(50.63%↑ Y/Y)
Collaboration profit
sharing/(loss reimbursement)
$75,000K
(20.19%↑ Y/Y)
Acquired in-process
research and...
$46,600K
Business combination,
contingent consideration,...
$13,200K
Cost of sales,
excluding amortization...
$605,000K
(10.81%↑ Y/Y)
Other (income)
expense, net
-$48,700K
(42.84%↑ Y/Y)
Research and development
$399,000K
(-22.36%↓ Y/Y)
Selling, general and
administrative
$583,800K
(5.42%↑ Y/Y)
Back